Notice of Results
Abingdon Health plc will announce its final results for the year ended 30 June 2026 on Tuesday, 13 October 2026, and will host a live online investor presentation at 11:00 BST on the same day via the Investor Meet Company platform. The company, a developer and manufacturer of rapid diagnostic tests and med-tech, is inviting existing and potential shareholders to attend this presentation, where questions can be submitted in advance or during the event.
Select text to share a quote on X · sign in to keep highlights & notes in your ABDX notes
York, UK and Madison, WI, USA, 7 October 2026: Abingdon Health plc (AIM: ABDX) (OTCQB: ABDXF), a leading international developer, manufacturer and regulatory services provider for rapid diagnostic tests and med-tech, will announce its final results for the year ended 30 June 2026 on Tuesday 13 October 2026.
Investor Presentation
The Company will provide a live online presentation relating to the final results via the Investor Meet Company platform on Tuesday 13 October 2026 at 11:00 BST. The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via the Investor Meet Company dashboard up until 09:00 BST the day before the meeting or at any time during the live presentation.
Investors can sign up to Investor Meet Company for free and add to meet Abingdon Health plc via: https://www.investormeetcompany.com/abingdon-health-plc/register-investor
Investors who already follow Abingdon Health plc on the Investor Meet Company platform will automatically be invited.
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.